Longitudinal Immunoblotting Variations of Auto-Antibody Reactivity of Patients with Systemic Lupus Erythematosus

References

• Tan E M, Chan E KL, Sullivan K F, Rubin R L. Antinuclear antibodies (ANA's): diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity. Clin Immunol Immunopathol 1988; 41: 121–141
   Google Scholar
• Swaak A JG, Aarden L A, Statius van eps L W, Feltkamp T EW. Anti-ds DNA and complement profiles as prognostic guides in systemic lupus erythematosus. Arthritis Rheum 1979; 22: 226–235
   PubMed Web of Science ®Google Scholar
• McCarty G, Rice J R, Bembe M L, Pisetsky D S. Independent expression of autoantibodies in systemic lupus erythematosus. J Rheumaiol 1982; 9: 691–695
   PubMed Web of Science ®Google Scholar
• Homma M, Mimori T, Takeda Y, Akama H, Yoshida T, Ogasawara T, et al. Autoantibodies to the Sm antigen: immunological approach to clinical aspects of systemic lupus erythematosus. J Rheumatol 1987; 14(suppl. 13)188–193
   Google Scholar
• Van Venrooij W J. Autoantibodies against small nuclear ribonucleoprotein components. J Rheumarol 1987; 14(Suppl 13)78–82
   Google Scholar
• Barada F A, Andres B S, Davis J S, Taylor R P. Antibodies to Sm in patients with systemic lupus erythematosus. Correlation of Sm antibody titers with disease activity and other laboratory parameters. Arthritis Rheum 1981; 24: 1236–1244
   PubMed Web of Science ®Google Scholar
• Borg E J ter, Horst G, Hummel E, Jaarsma D, Limburg P C, Kallenberg G GM. Sequential development of antibodies to specific Sm polypeptides in a patient with systemic lupus erythematosus: evidence for independent regulation of anti-double stranded DNA and anti-Sm antibody production. Arthritis Rheum 1988; 31: 1563–1567
   PubMedGoogle Scholar
• Habets W J, De Rooij D J, Hoet M H, Van de Putte L B, Venrooij W J. Quantitation of anti-RNP and anti-Sm antibodies in MCTD and SLE patients by immunoblotting. Clin Exp Immunol 1985; 59: 457–466
   PubMed Web of Science ®Google Scholar
• Houtman P M, Kallenberg C GM, Limburg P C, Huitema M G, Van Rijwijk M H, et al. Quantitation of antibodies to ribonucleoprotein by ELISA: relation between antibody levels and disease activity in patients with connective tissue disease. Clin Exp Immunol 1985; 62: 696–704
   PubMed Web of Science ®Google Scholar
• Takeda Y, Wang G S, Wang R J, Anderson S K, Petterson I, Amaki S, et al. Enzyme linked immunosorbent assay using isolated (U) small nuclear ribonucleoprotein polypeptides as antigens to investigate the clinical significance of autoantibodies to these polypeptides. Clin Immunol Immunopathol 1989; 50: 213–230
   PubMedGoogle Scholar
• Petterson I, Wang G, Smith E I, Wigzell H, Hedfors E, Horn J, et al. The use of immunoblotting and immunoprecipitation of (U) small nuclear ribonucleoproteins in the analysis of sera of patients with mixed connective tissue disease and systemic lupus erythematosus. A cross-sectional longitudinal study. Arthritis Rheum 1986; 29: 986–996
   PubMedGoogle Scholar
• Fisher D E, Reeves W H, Wisniewolski R, Lahita R G, Chiorazzi N. Temporal shifts from Sm to ribonucleoprotein reactivity in systemic lupus erythematosus. Arthritis Rheum 1985; 28: 1348–1355
   PubMed Web of Science ®Google Scholar
• Tan E M, Cohen A S, Fries J F, Masi A T, McShane D J, Rothfield N F, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–1277
   PubMed Web of Science ®Google Scholar
• Lightfoot R W, Hughes G RV. Significance of persisting serologic abnormalities in SLE. Arthritis Rheum 1976; 19: 837–843
   PubMed Web of Science ®Google Scholar
• Swaak A JG, Nossen J C, Bronsveld W, Van Rooyen A, Nieuwenhuys E J, Theuns L, et al. Systemic lupus erythematosus. I. Outcome and survival: Dutch experience with 110 patients studied prospec-tively. Ann Rheum Dis 1989; 48: 447–454
   PubMed Web of Science ®Google Scholar
• Jonsson H, Nived O, Sturfeld G. Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population. Medicine 1989; 68: 141–150
   PubMed Web of Science ®Google Scholar
• Morrow W JW, Isenberg D A, Todd-Pokropek A, Parry H G, Snaith M L. Useful laboratory measurements in the management of systemic lupus erythematosus. Quart J Med 1982; 51: 125–138
   PubMedGoogle Scholar
• Fritzler M J, Tan E M. Antinuclear antibodies and the connective tissue diseases. Laboratory diagnostic procedures in the rheumatic diseases, Third ed., A S Cohen. Grune and Stratton, New York 1985
   Google Scholar
• Aarden L A, Groot E R, Feltkamp T EW. Immunology of DNA. III Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique. Ann NY Acad Sci 1975; 264: 505–515
   Google Scholar
• Aeschlimann A, Meyer O, Bourgeois P, Haim T, Belmatoug N, Palazzo E, et al. Anti-Scl 70 antibodies detected by immunoblotting in progressive systemic sclerosis: specificity and clinical correlations. Ann Rheum Dis 1989; 48: 594–599
   PubMed Web of Science ®Google Scholar
• Laemmli U K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1979; 227: 680–685
   Web of Science ®Google Scholar
• Towbin H, Staehelin T, Gordon J. Electrophoretic transfer to proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350–5354
   PubMed Web of Science ®Google Scholar
• Tan E M. ILAR/IUIS international ANA committee: Reference reagents for antinuclear antibodies. Arthritis Rheum 1988; 31: 1331
   Google Scholar
• Field M, Williams D G, Charles P, Maini R W. Specificity of anti-Sm antibodies by ELISA for systemic lupus erythematosus: increased sensitivity of detection using purified peptide antigens. Ann Rheum Dis 1988; 47: 820–825
   PubMed Web of Science ®Google Scholar
• Maddison P J, Skinner R P, Vlachoyiannopoulos P, Brennand D M, Hough D. Antibodies to RNP, Sm, Ro (SS-A) and La (SS-B) detected by ELISA: their specificity and inter-relations in connective tissue disease sera. Clin Exp Immunol 1985; 62: 337–345
   PubMed Web of Science ®Google Scholar
• Westgeest A AA, Van Den Brink H G, De Jong J, Swaak A JG, Smeenk R JJ. Antinuclear antibodies in patients with systemic lupus erythematosus: a comparison of counterimmunoelectrophoresis and immunoblotting. Rheumatol Int 1987; 7: 77–82
   PubMed Web of Science ®Google Scholar
• Beaufils M, Kouki F, Mignon F, Camus J P, Morel Maroger L, Richet G. Clinical significance of anti-Sm antibodies in systemic lupus erythematosus. Amer J Med 1983; 74: 201–205
   PubMed Web of Science ®Google Scholar
• Munves E F, Schur P H. Antibodies to Sm and RNP. Prognostication of disease involvement. Arthritis Rheum 1983; 26: 848–853
   PubMedGoogle Scholar
• Winn D M, Wolfe J F, Lindberg D A, Fristoe F H, Kingsland L, Sharp G C. Identification of a clinical subset of systemic lupus erythematosus by antibodies to the Sm antigen. Arthritis Rheum 1979; 22: 1334–1334
   PubMed Web of Science ®Google Scholar